HIV- (n = 450) | HIV + (n = 90) | p–Value* | Overall (n = 540) | |
COVID-19 preventive measures | ||||
Wearing a mask | 430 (95.6%) | 86 (95.6%) | 0.998 | 516 (95.6%) |
Keeping distance | 191 (42.4%) | 36 (40.0%) | 0.726 | 227 (42.0%) |
Avoiding crowded areas | 167 (37.1%) | 28 (31.1%) | 0.336 | 195 (36.1%) |
Hand wash | 374 (83.1%) | 77 (85.6%) | 0.643 | 451 (83.5%) |
HIV- (n = 220) | HIV + (n = 33) | Overall (n = 253) | ||
COVID-19 Symptomsa (N/A = 12) | ||||
Total with symptoms | 61 (29.2%) | 7 (21.9%) | 0.527 | 68 (28.2%) |
Fever | 47 (22.5%) | 6 (18.8%) | 0.820 | 53 (22.0%) |
Cough | 49 (23.4%) | 6 (18.8%) | 0.821 | 55 (22.8%) |
Sore throat | 38 (18.2%) | 3 (9.4%) | 0.315 | 41 (17.0%) |
Anosmia | 14 (6.7%) | 1 (3.1%) | 0.701 | 15 (6.2%) |
Breathing difficulty | 3 (1.4%) | 2 (6.3%) | 0.128 | 5 (2.1%) |
Hospitalization | 0 (0.0%) | 0 (0.0%) | 0.998 | 0 (0.0%) |